DE3751777T2 - Impfstoff, der zecken-antigene enthält - Google Patents

Impfstoff, der zecken-antigene enthält

Info

Publication number
DE3751777T2
DE3751777T2 DE3751777T DE3751777T DE3751777T2 DE 3751777 T2 DE3751777 T2 DE 3751777T2 DE 3751777 T DE3751777 T DE 3751777T DE 3751777 T DE3751777 T DE 3751777T DE 3751777 T2 DE3751777 T2 DE 3751777T2
Authority
DE
Germany
Prior art keywords
antigen
ticks
wgl
sequence
spp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3751777T
Other languages
German (de)
English (en)
Other versions
DE3751777D1 (de
Inventor
Gary Cobon
Law Johnston
David Kemp
Joanna Moore
Keith Rand
George Riding
Alagacone Sriskantha
Peter Willadsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organisation
Biotech Australia Pty Ltd
Original Assignee
Commonwealth Scientific and Industrial Research Organisation
Biotech Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commonwealth Scientific and Industrial Research Organisation, Biotech Australia Pty Ltd filed Critical Commonwealth Scientific and Industrial Research Organisation
Publication of DE3751777D1 publication Critical patent/DE3751777D1/de
Application granted granted Critical
Publication of DE3751777T2 publication Critical patent/DE3751777T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43527—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from ticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/127—RNA-directed RNA polymerase (2.7.7.48), i.e. RNA replicase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Insects & Arthropods (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE3751777T 1986-11-27 1987-11-27 Impfstoff, der zecken-antigene enthält Expired - Fee Related DE3751777T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPH919686 1986-11-27
AUPI257087 1987-06-19
AUPI491287 1987-10-16
PCT/AU1987/000401 WO1988003929A1 (en) 1986-11-27 1987-11-27 Vaccine containing tick antigens

Publications (2)

Publication Number Publication Date
DE3751777D1 DE3751777D1 (de) 1996-05-23
DE3751777T2 true DE3751777T2 (de) 1997-01-09

Family

ID=27157333

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3751777T Expired - Fee Related DE3751777T2 (de) 1986-11-27 1987-11-27 Impfstoff, der zecken-antigene enthält

Country Status (12)

Country Link
EP (1) EP0290565B1 (enExample)
JP (1) JP2811190B2 (enExample)
AR (1) AR248046A1 (enExample)
AT (1) ATE136903T1 (enExample)
BR (1) BR8707549A (enExample)
DE (1) DE3751777T2 (enExample)
IL (1) IL84574A (enExample)
IN (1) IN165830B (enExample)
MY (1) MY101874A (enExample)
NZ (1) NZ222717A (enExample)
WO (1) WO1988003929A1 (enExample)
ZW (1) ZW22487A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225295A (en) 1987-07-07 1991-07-26 Biotech Australia Pty Ltd Nematode antigen, its production and vaccines containing it
US5344645A (en) * 1991-03-22 1994-09-06 Center For Innovation And Business Development Foundation Immunogens derived from pathogen-free tick species or cell lines, and tick vaccines derived therefrom
US5418137A (en) * 1991-09-26 1995-05-23 Paravax, Inc. Flea membrane binding site proteins as screening tools
WO1994006463A1 (en) * 1992-09-14 1994-03-31 Pfizer Inc Immortalized cells and uses therefor
NZ522301A (en) 2000-04-25 2004-11-26 Evolutec Ltd Vaccine comprising a tick cement protein
WO2011031139A1 (en) * 2009-09-09 2011-03-17 Universiteit Utrecht Holding B.V. An ataq protein or a part thereof as a vaccine
GB201112587D0 (en) * 2011-07-22 2011-09-07 Moredun Res Inst Vaccine
US9579369B2 (en) 2013-03-29 2017-02-28 Intervet Inc. Vaccine against Rhipicephalus ticks
BR102013026625B1 (pt) 2013-10-16 2022-04-26 Universidade Federal de Viçosa Vacina de peptídeos recombinantes para o controle de carrapatos e sequências de nucleotídeos codificadoras dos peptídeos recombinantes
US11623945B2 (en) 2017-02-06 2023-04-11 The United States Of America, As Represented By The Secretary Of Agriculture Immunostimulating compositions and uses therefore
US20250082724A1 (en) 2023-09-12 2025-03-13 Institut Pasteur De Montevideo Versatile immunogenic modules and nanoparticles for tick vaccines

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU569252B2 (en) * 1982-07-12 1988-01-28 Commonwealth Scientific And Industrial Research Organisation Tick paralysis vaccines and toxins
GB2142334B (en) * 1983-03-14 1986-08-28 Int Centre Of Insect Physiolog Immunogenic preparations
AU598445B2 (en) * 1984-08-08 1990-06-28 Commonwealth Scientific And Industrial Research Organisation Antigenic extracts derived from boophilus microplus
AU592997B2 (en) * 1985-07-03 1990-02-01 Pitman-Moore Australia Limited Tick vaccine

Also Published As

Publication number Publication date
EP0290565A4 (en) 1990-03-12
MY101874A (en) 1992-01-31
JPH01502115A (ja) 1989-07-27
IN165830B (enExample) 1990-01-20
JP2811190B2 (ja) 1998-10-15
WO1988003929A1 (en) 1988-06-02
EP0290565A1 (en) 1988-11-17
ZW22487A1 (en) 1989-06-21
EP0290565B1 (en) 1996-04-17
ATE136903T1 (de) 1996-05-15
IL84574A (en) 1994-10-07
NZ222717A (enExample) 1991-07-26
BR8707549A (pt) 1989-02-21
AR248046A1 (es) 1995-05-31
DE3751777D1 (de) 1996-05-23

Similar Documents

Publication Publication Date Title
DE3586853T2 (de) Immunologisch aktive Peptide, geeignet zur Einführung von Immunisierung gegen Malaria und deren Kodierung von Genen.
DE3854952T2 (de) Mykobakterielle rekombinanten und peptide
EP0633313B1 (de) Impfstoff gegen die Lyme-Krankheit
DE3650540T2 (de) Antigene Proteine und diese enthaltende Impfstoffe zur Verhütung von Kokzidiose
DE3586609T2 (de) Antigenische proteine, dieselben enthaltende vakzine, schuetzende antikoerper dagegen fuer die verhuetung von durch eimeria tenella verursachte coccidiosis.
DE69432658T2 (de) Rib-protein, ein oberflächenprotein welches immunität gegen viele streptococcus-stämme der gruppe b verleiht, reinigungsverfahren für das rib-protein, testsatz und pharmazeutische zusammenstellung (arznei)
DE69225357T2 (de) Impfstoff gegen Geflügelkokzidose
DE3650689T2 (de) Rekombinantes inhibin
DE68907254T2 (de) Rekombinante und natürliche Eimeria tenella immunogens der Gruppe B, die für Coccidiosis-Impfstoffe verwendbar sind.
DE69121423T2 (de) Rekombinante vakzine gegen coccidiose
DE3751670T2 (de) Coccidiosis-Impfstoff
DE69101646T2 (de) Vakzine gegen Coccidiose.
DE69635472T2 (de) Impfstoff gegen Geflügelkokzidose
DE3788852T2 (de) Proteine mit Glutathion-S-Transferase-Aktivität, DNA-Sequenzen, Antikörper, Poxviren und Arzneimittel zur Prävention von Schistosomiasis.
DE68918712T2 (de) Rekombinante Eimeria tenella-Vakzine.
EP0290565B1 (en) Vaccine containing tick antigens
DE3875043T2 (de) Immunogenes produkt, erhalten durch expression in einer rekombinanten hefe, und verfahren zu seiner reinigung.
DE69737691T2 (de) Impfstoff, der peroxiredoxin enthält
DE69301733T2 (de) Impfstoffe gegen Metazoen-Parasiten
DE69205243T2 (de) Impfstoff gegen nematoden.
DE68927350T2 (de) Gentechnologisch hergestellter coccidiose-impfstoff
DE68926712T2 (de) Gen zum kodieren eines antigens gegen menschlichen malaria impfstoff
DE60220988T2 (de) Herstellung und verwendung eines plasmodiumfusionsantigen
DE69330385T2 (de) Schützende antigene gegen eine (echinococcus granulosus) infektion und impfstoffe die entsprechende antigene enthalten
DE69206075T2 (de) Impfstoff gegen nematoden.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee